ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FWBI First Wave BioPharma Inc

2.82
0.09 (3.30%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 45,316
Bid Price 2.66
Ask Price 2.99
News -
Day High 2.81

Low
2.42

52 Week Range

High
64.998

Day Low 2.55
Share Name Share Symbol Market Stock Type
First Wave BioPharma Inc FWBI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.09 3.30% 2.82 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.67 2.55 2.81 2.74 2.73
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
278 45,316 US$ 2.68 US$ 121,228 - 2.42 - 64.998
Last Trade Type Quantity Price Currency
16:37:54 formt 200 US$ 2.82 USD

First Wave BioPharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.85M 675.00k - 0 -16.1M -23.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

First Wave BioPharma News

Date Time Source News Article
4/24/202406:00GlobeNewswire Inc.First Wave BioPharma Announces Invited Paper for Special..
4/17/202406:00GlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Present at the..
4/15/202406:00GlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Participate in..
3/18/202406:00GlobeNewswire Inc.First Wave BioPharma Announces Two Abstracts on Celiac..
3/14/202405:00GlobeNewswire Inc.First Wave BioPharma Announces Completion of Business..
3/05/202416:26Edgar (US Regulatory)Form 8-K - Current report
3/05/202406:00GlobeNewswire Inc.First Wave BioPharma to Participate In ‘Fireside Chat’ at..
3/04/202416:29Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202407:00GlobeNewswire Inc.First Wave BioPharma, Inc. to Raise Approximately $4.0..
2/13/202406:00GlobeNewswire Inc.First Wave BioPharma CEO to Present at the BIO CEO &..
1/23/202406:00GlobeNewswire Inc.First Wave BioPharma to Present at the DealFlow MicroCap..
1/18/202415:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FWBI Message Board. Create One! See More Posts on FWBI Message Board See More Message Board Posts

Historical FWBI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.023.39992.422.9282,234-0.20-6.62%
1 Month4.584.582.423.2548,142-1.76-38.43%
3 Months5.209.352.425.5594,640-2.38-45.77%
6 Months5.6014.512.425.38476,633-2.78-49.64%
1 Year56.8064.9982.4214.461,594,256-53.98-95.04%
3 Years483.00686.002.4298.221,444,307-480.18-99.42%
5 Years483.00686.002.4298.221,444,307-480.18-99.42%

First Wave BioPharma Description

First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

Your Recent History

Delayed Upgrade Clock